Pronounce: oh-LANZ-a-peen
Classification: Atypical antipsychotic
Olanzapine is an antipsychotic medication approved for the treatment of schizophrenia, bipolar I disorder, and depression that is resistant to other treatments. Olanzapine, given in lower doses than that used to treat mood disorders and when given with other anti-nausea medications, can also be used to treat nausea and vomiting caused by cancer treatments. Olanzapine targets receptors in the brain that have been linked to nausea and vomiting. This medication sheet will focus on the use of olanzapine as an anti-nausea (antiemetic) medication.
This medication comes in oral tablets, orally disintegrating tablets, and as an intramuscular (IM) injection. When using olanzapine to prevent nausea and vomiting due to cancer treatments, it is given orally (by mouth).
This medication is usually given once daily. If you are taking the orally disintegrating tablet version, peel back the foil on the blister pack (do not push tablet through the foil) and remove it from the blister pack with dry hands. The whole disintegrating tablet should be placed on the tongue and allowed to disintegrate (melt or dissolve) without chewing or crushing it. Once it has disintegrated, you should swallow the saliva in your mouth. The oral tablet can be taken with or without food.
The dose and how often you take olanzapine depends on the cancer treatment you are getting. Most times, olanzapine is given for 4 days while you are receiving treatment. It is often given with 3 or 4 other medications used to prevent or treat nausea and vomiting. Ask your care team if olanzapine will be a part of your treatment plan and how/when you should take it.
Tell your provider about any medications or supplements you take. Olanzapine can interact with other medications and supplements, including buprenorphine, carbamazepine, diazepam, fluvoxamine, levodopa/dopamine agonists, lorazepam, metoclopramide, and medications that lower blood pressure, among others. If you take any medications that affect the central nervous system (CNS), be sure to tell your care team before taking olanzapine.
You should not drink alcohol while taking olanzapine. You should not drive a car or operate heavy machinery until you know how olanzapine affects you.
Store this medication in the original container. For tablets and orally disintegrating formulations, store at room temperature. Keep this medication out of reach of children and pets.
This medication is available through retail/mail order pharmacy. Your oncology team will work with your prescription drug plan to identify an in-network retail/mail order pharmacy for medication distribution. You can work with your provider’s office if this medication needs a prior authorization.
Olanzapine may be covered under your prescription drug plan. Patient assistance may be available to qualifying individuals without prescription drug coverage. Co-pay cards, which reduce the patient co-pay responsibility for eligible commercially (non-government sponsored) insured patients may also be available. Your care team can help you find these resources if they are available.
This medication is given to manage and/or prevent side effects of your cancer treatment. If you are having side effects from this medication, you should talk to your team about if this medication is necessary to your treatment or if there are other options to help manage the side effect this medication is treating. These are some of the most common side effects:
Elderly patients who have a history of dementia should not take olanzapine. These patients have an increased risk of death and heart problems, including blood clots and stroke. Symptoms can include: swelling, redness or pain in an extremity, chest pain or pressure, pain in your arm, back, neck or jaw, shortness of breath, numbness or weakness on one side of the body, trouble talking, confusion or mental status changes. If you experience any of these symptoms, you should contact your oncology care team immediately or go to an emergency room.
Because of how this medication works and its effects on neurotransmitters in the brain, olanzapine may cause drowsiness, fatigue, sedation, dizziness, and weakness. If these effects make it hard to carry out daily life, talk with your provider. Again, you should not drink alcohol while taking olanzapine. You should not drive a car or operate heavy machinery until you know how olanzapine affects you.
This medication can cause xerostomia, also known as dry mouth. Xerostomia can be uncomfortable and can affect your speech, swallowing, and dental health. Ways to manage this side effect include:
Speak to your provider if this side effect continues to be a problem.
Olanzapine may increase your appetite. Because you will likely be taking olanzapine only for a few days during treatment, weight gain should not be an issue. With prolonged chronic use, you may gain weight. Talk with your healthcare team if you have concerns about this.
Olanzapine can lower your blood pressure, especially when going from lying or sitting to standing. Call your care team if you feel dizzy or lightheaded. Take your time when going from a lying to a sitting and standing position. Your healthcare team may suggest taking your dose in the evenings to lower this risk. Confirm what time of day your prescriber wants you to take the medication.
You should consult with your provider before becoming pregnant or fathering a child while on this medication. You should consult with your healthcare team before breastfeeding while receiving this medication. Olanzapine may impair fertility in men and women with reproductive potential. Talk to your provider about these risks.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania